Trademark: 88057968
Status Date
Tuesday, September 8, 2020
Registration Number
6148102
Registration Date
Tuesday, September 8, 2020
Filing Date
Monday, July 30, 2018
Published for Opposition
Tuesday, January 1, 2019
5 Pharmaceuticals, namely, anti-cancer drugs containing platinum-based antineoplastic agents
Sep 8, 2020
Registered-Principal Register
Aug 1, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 31, 2020
Allowed Principal Register - Sou Accepted
Jul 31, 2020
Examiner's Amendment Entered
Jul 31, 2020
Notification Of Examiners Amendment E-Mailed
Jul 31, 2020
Examiners Amendment E-Mailed
Jul 31, 2020
Su-Examiner's Amendment Written
Jul 30, 2020
Statement Of Use Processing Complete
Jul 15, 2020
Use Amendment Filed
Jul 30, 2020
Case Assigned To Intent To Use Paralegal
Jul 15, 2020
Teas Statement Of Use Received
Jun 27, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 25, 2020
Extension 2 Granted
Jun 25, 2020
Extension 2 Filed
Jun 25, 2020
Teas Extension Received
Dec 19, 2019
Notice Of Approval Of Extension Request E-Mailed
Dec 17, 2019
Extension 1 Granted
Dec 17, 2019
Extension 1 Filed
Dec 17, 2019
Teas Extension Received
Jun 25, 2019
Noa E-Mailed - Sou Required From Applicant
May 12, 2019
Extension Of Time To Oppose Process - Terminated
Jan 24, 2019
Extension Of Time To Oppose Received
Jan 1, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 1, 2019
Published For Opposition
Dec 12, 2018
Notification Of Notice Of Publication E-Mailed
Nov 21, 2018
Approved For Pub - Principal Register
Nov 15, 2018
Assigned To Examiner
Aug 3, 2018
New Application Office Supplied Data Entered In Tram
Aug 2, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
